August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Diego Díaz García: Overall Survival and Quality-of-Life Superiority in Modern Phase 3 Oncology Trials
Jun 22, 2025, 11:09

Diego Díaz García: Overall Survival and Quality-of-Life Superiority in Modern Phase 3 Oncology Trials

Diego Díaz García, Medical Oncologist, CEO and Founder of CánCare, posted on X:

“Are we overestimating success in ph3 oncology trials?
Only 6% of ph3 oncology RCTs show improvement in both OS and QoL.
Most “positive” trials rely on surrogate endpoints, often without adjusting QoL for baseline. We must refocus trials on what truly matters to patients.”

Title: Overall Survival and Quality-of-Life Superiority in Modern Phase 3 Oncology Trials

Authors: Alexander D. Sherry, Avital M. Miller, Jnana Preeti Parlapalli, Gabrielle S. Kupferman, Esther J. Beck, Jordan McDonald, Ramez Kouzy, Joseph Abi Jaoude, Timothy A. Lin, Nina N. Sanford, Fumiko Chino, Bishal Gyawali, Christopher Booth, Pavlos Msaouel, Ethan B. Ludmir

Read The Full Article at JAMA Oncology.

Diego Díaz García: Overall Survival and Quality-of-Life Superiority in Modern Phase 3 Oncology Trials

More posts featuring Diego Díaz García.